Ossmiq (Posaconazole)

Posaconazole, the active ingredient in Ossmiq, is an azole antifungal presented as a unknown/unknown for oral use. It treats invasive fungal infections such as aspergillosis and candidiasis in immunocompromised patients. GNH USA supplies Ossmiq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

GNH USA supplies Ossmiq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Ossmiq is an azole antifungal that targets  the  development  of  fungal  pathogens  across  several  disease  families.

- Aspergillosis:  achieves  the  prevention  and  treatment  of  invasive  aspergillosis  in  high  risk  patients. - Candid  ​  ​                  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​-                              ​  ​ -   -  

There        …  …  …  ...  ....  …  …  ...  …   …  …